1.Bennett D.C. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003; 22: 3063-9.2.Herlyn M„ Thurin J., Balaban G. et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res. 1985:45: 5670-6.3.Cramer S.F. The neoplastic development of malignant melanoma. A biological rationale. Am. J. Dermatopathol. 1984; 6: 299-308.4.Grichnik J.M., Ali W.N., Burch J.A. et al. Kit expression reveals a population of precursor melanocytes in human skin. J. Invest. Dermatol. 1996; 106: 967-71.5.Nishimura E.K., Jordan S.A., Oshima H. et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002; 416: 854-60.6.Reya T„ Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-11.7.Al—Hajj M., Wicha M.S., Benito-Hernandez A. et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003; 100: 3983-8.8.Hochedlinger K., Blelloch R., Brennan C. et al. Reprogramming of a melanoma genome by nucleartransplantation. Genes Dev. 2004; 18:1875-85.9.Singh S.K., Hawkins C., Clarke I.D. et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.10.Dontu G., Abdallah W.M., Foley J.M. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003; 17: 1253-70.11.Le Douarin N.M., Kalcheim C. fed.). The neural crest. “Cambridge University Press” 1999, Cambridge [UK).12.Fang D., Hallman J., Sangha N. et al. Expression of microtubule- associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Am. J. Pathol. 2001; 158: 2107-15.13.Brooker E.B., Magiera H., Herlyn M. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J. Invest. Dermatol. 1991;96:662-5.